Medline Overview
Medline Target Price
Analysts' 12-month price predictions for MDLN.
Get informed when a big investor buys or sells
+ FollowShare Price
$35.3
Average Target Price
$51.14
44.9% upside
44.9% upside7 analysts in the last 4 months
High: $60 | Low: $42
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-03 | Robert W. BairdEric Coldwell | $45 | 27.5% upside |  |
| 2026-06-01 | BarclaysGlen Santangelo | $45 | 27.5% upside | |
| 2026-05-07 | Deutsche Bank | $42 | 19% upside | |
| 2026-03-09 | Tigress FinancialIvan Feinseth | $60 | 70% upside | |
| 2026-02-25 | Leerink PartnersMichael Cherny | $56 | 58.6% upside | |
| 2026-02-25 | Stifel Nicolaus | $55 | 55.8% upside | |
| 2026-02-25 | Evercore ISI | $55 | 55.8% upside | |
| 2026-02-05 | Tigress Financial | $55 | 55.8% upside | |
| 2026-01-21 | J.P. MorganDavid Larsen | $55 | 55.8% upside | |
| 2026-01-12 | Barclays | $50 | 41.6% upside | |
| 2026-01-12 | BNP Paribas | $38 | 7.6% upside | |
| 2026-01-12 | Wolfe Research | $47 | 33.1% upside | |
| 2026-01-12 | Deutsche Bank | $40 | 13.3% upside | |
| 2026-01-12 | Wells Fargo | $42 | 19% upside | |
| 2026-01-12 | BTIG | $50 | 41.6% upside | |
| 2026-01-12 | Mizuho Securities | $48 | 36% upside | |
| 2026-01-12 | UBS | $48 | 36% upside | |
| 2026-01-12 | Stifel Nicolaus | $46 | 30.3% upside | |
| 2026-01-12 | Redburn PartnersEd Ridley-Day | $42 | 19% upside | |
| 2026-01-12 | Leerink Partners | $48 | 36% upside | |
| 2026-01-12 | Evercore ISIElizabeth Anderson | $50 | 41.6% upside | |
| 2026-01-12 | Bernstein | $49 | 38.8% upside | |
| 2026-01-12 | Truist Financial | $52 | 47.3% upside | |
| 2026-01-12 | Piper SandlerJason Bednar | $50 | 41.6% upside | |
| 2026-01-12 | Robert W. BairdEric Coldwell | $48 | 36% upside | |
| 2026-01-12 | BMO CapitalSean Dodge | $45 | 27.5% upside | |
| 2026-01-12 | Goldman SachsDavid Roman | $49 | 38.8% upside | |
| 2026-01-12 | RBC Capital | $47 | 33.1% upside | |
| 2026-01-11 | Morgan StanleyPatrick Wood | $48 | 36% upside | |